SPX3,678.43+92.81 2.59%
DIA294.79+7.49 2.61%
IXIC10,815.44+239.82 2.27%

BRIEF-Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19

BRIEF-Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19

Reuters · 09/14/2022 07:10
BRIEF-Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19

- Valeo Pharma Inc VPH.TO:

  • VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

  • VALEO PHARMA INC - VERU WILL BE REQUESTING THAT HEALTH CANADA UTILIZE ACCESS CONSORTIUM REGULATORY PATHWAY

  • ALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT RISK FOR ARDS

Source text for Eikon: ID:

Further company coverage: VPH.TO


((Reuters.Briefs@thomsonreuters.com;))